The expanding incretin universe: from basic biology to clinical translation
Diabetologia · 2023-10 · 66 (10) · 1765-1779
DOI: 10.1007/s00125-023-05906-7 ↗At a glance
Übersichtsarbeit in Diabetologia, published online on 2023-03-28. Written by Daniel J Drucker and 1 co-authors. Institution: Department of Medicine, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. drucker@lunenfeld.c…. Major MEDLINE topics: Incretins, Diabetes Mellitus, Type 2. Cited 245 times so far (Crossref); 174 references. Funded by: CIHR.
Abstract (original language)
Ebda abstract disponibbli.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medicine, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. drucker@lunenfeld.ca.
- The Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID profiles: Daniel J Drucker, Jens J Holst
Funding
- CIHR
Cite
APA
Drucker, D. J., & Holst, J. J. (2023). The expanding incretin universe: from basic biology to clinical translation. Diabetologia, 66(10), 1765-1779. https://doi.org/10.1007/s00125-023-05906-7
Vancouver
Drucker DJ, Holst JJ. The expanding incretin universe: from basic biology to clinical translation. Diabetologia. 2023;66(10):1765-1779. doi:10.1007/s00125-023-05906-7
BibTeX
@article{Drucker2023,
author = {Drucker, Daniel J and Holst, Jens J},
title = {The expanding incretin universe: from basic biology to clinical translation},
journal = {Diabetologia},
year = {2023},
volume = {66},
number = {10},
pages = {1765--1779},
doi = {10.1007/s00125-023-05906-7}
}
EUVIMED